In the News
More than half of prostate cancer patients age 66 years and older have life expectancies of less than 10 years, yet half of them were over-treated for their prostate cancer with surgery, radiation, or brachytherapy.
An oral drug called ASP8273 caused tumor shrinkage in patients in a phase I clinical trial, according to research presented at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
Counseling from a health care professional trained in genetics before genetic testing takes place may improve the quality of health care.
A blue-ribbon team of national experts stated that professional pessimism and out-of-date myths rather than current science may compromise the care of patients with brain cancer.
Cancer cells decide whether to live or die after a short period of intense exposure to targeted therapy, opposing the current requirement for continuous treatment, according to a new study.
Many patients skip doses or stop taking medication entirely when their share of the costs becomes too high.
The American Cancer Society (ACS) has published its latest annual report on cancer incidence and mortality, and the news is good.
A new challenge for health care providers is emerging from the improved prognosis for patients with cancer: the need to include this growing group of patients in health promotion campaigns.
Women with breast cancer who undergo surgery rate persistent postmastectomy pain as the most troubling symptom.
An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with advanced, BRCA-related breast and ovarian cancers.
A definitive trial has indicated that low-level laser therapy (LLLT) reduces the occurrence of canker sores and improves quality of life in patients with head and neck squamous cell carcinoma.
Oncology nurse navigators (ONNs) are clinical professionals acting as a map or compass through the confusing process of diagnosis, treatment, and survivorship.
New findings that run counter to federal recommendations indicate that women should be encouraged to initiate regular mammographic screening before age 50 years.
Persons with head and neck cancer who are undergoing radiation or chemoradiation can preserve swallow function by exercising involved muscles before, during, and after treatment.
Researchers have not only confirmed that tamoxifen induces cognitive dysfunction in users, they have also found an existing treatment that can prevent this adverse effect.
The US cancer care delivery system is in crisis and changes across the board are urgently needed to improve the quality of cancer care, concludes the Institute of Medicine of the National Academies in its new report.
The Oncology Nursing Society has released a joint position statement on key issues surrounding the implementation of screening programs for psychosocial distress in cancer centers.
Changes made 5 years ago to accelerate time-to-initiation of clinical trials sponsored by the National Cancer Institute have paid off in the form of faster activation of studies.
Demonstrating the value of patient navigation programs is essential for sustaining these initiatives in community cancer centers, and nurses play a key role.
Clinicians should discuss the prophylactic use of tamoxifen as well as two other agents with women 35 years and older and at increased risk of ER-positive breast cancer, per ASCO recommendations.
The AUA developed its new clinical guideline on castration-resistant prostate cancer by creating six index patients to represent the most common clinical scenarios encountered when managing the disease.
Despite the low risk of lymphedema after sentinel lymph node biopsy, most women worry about this complication and practice risk-reducing behaviors to avoid it.
Investigators reported that levels of support within relationships were important risk factors for breast cancer mortality.
Paclitaxel protein-bound particles for injectable suspension, 90-minute infusion of rituximab, omacetaxine mepesuccinate receive FDA approval
The ONS Leadership Competencies provides a means for self-assessment and a foundation for future leadership education.
A new Survivorship Toolkit offers patients posttreatment self-care plans, wallet-sized information cards, and a calendar for keeping track of appointments.
These guidelines are the first clinical practice guidelines issued by ASCO since 2006.
Earlier study findings that anthracycline- or trastuzumab-based treatment for breast cancer raises the risk for heart failure and cardiomyopathy can be extended to a more general population of women.
Differences in the impact of aspirin in various forms of cancer are highlighted in two studies recently published in the oncology literature.
News from the FDA on bosutinib (Bosulif), ziv-aflibercept (Zaltrap), and everolimus oral suspension tablets (Afinitor Disperz).
Support from oncology clinicians can encourage people with cancer to adopt an exercise regimen that can help relieve their symptoms and improve their function.
A certification program in blood and marrow transplantation nursing is being offered by the Oncology Nursing Certification Corporation, with the first BMTCN examination scheduled for February 2014.
The ruling preserves vital provisions that are already improving the ability of people with cancer to access needed care.
News about pertuzumab injection (Perjeta); ondansetron (Zofran); carfilzomib (Kyprolis); Therascreen KRAS RGQ PCR Kit; Prostate Health Index (phi); and Prepopik
People with cancer and their caregivers can turn to a new Web site to help answer the question from concerned relatives and friends, "What can I do to help?"
The grief experienced by the oncologists had unique elements beyond sadness, crying, and sleep loss.
Oncologists at M.D. Anderson Cancer Center found the key to screening for pancreatic cancer lies in the interpretation of preoperative CT scans.
Research results suggest that of the billions of cancer cells that exist in a patient, only about one in a million is resistant to drugs using targeted therapy.
Nurses seeking to hone their leadership, communication, technological, and professional "soft skills" can receive such training and education through a new interactive program.
USPSTF has issued a final recommendation against PSA-based screening for prostate cancer for all men, regardless of age.
A large UK study found a wide variation between cancer types in patients who had visited their general practitioner 3 or more times before cancer diagnosis.
Physicians have changed management recommendations for almost half of patients with known or suspected brain tumors after PET/CT findings.
CT colonography accurately detects cancer and precancerous polyps in persons aged 65 years and older.
More than 3,000 oncology nurses gathered in New Orleans for the 2012 Oncology Nursing Society Annual Congress.
Younger women at increased risk for breast cancer may benefit from mammography screening once every 2 years beginning at age 40 years.
Overall US cancer death rates have continued to decline since the early 1990s, but excess weight and lack of sufficient activity contribute to the increased incidence of many cancers.
Adding bisphosphonates to myeloma treatment decreases fractures of the vertebra and bone pain, affirm the results of a review of 20 trials.
Drug Safety Communication on lenalidomide (Revlimid); FDA approval for pazopanib (Votrient)
The Agency for Healthcare Research and Quality (AHRQ) released Statistical Brief #125 Cancer Hospitalizations for Adults, 2009.
Scientists have discovered that the Abraxas gene may advance the mission of BRCA1 and may even act on its own to help breast cancer develop.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|